| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 01/03/2003 | WO2003000905A2 Identification and characterization of plant genes |
| 01/03/2003 | WO2003000904A2 Identification and characterization of plant genes |
| 01/03/2003 | WO2003000903A2 Regulation of human nek-like serine/threonine protein kinase |
| 01/03/2003 | WO2003000902A1 Aphidicolin biosynthase cluster |
| 01/03/2003 | WO2003000901A2 Nucleic acids encoding protein kinases |
| 01/03/2003 | WO2003000897A2 Identification and characterization of phosphate transporter genes |
| 01/03/2003 | WO2003000884A2 Cytochrome p-450 gene cluster from rhodococcus ruber and uses thereof in ether fuel cleavage |
| 01/03/2003 | WO2003000882A2 Transgenic models for glucose homeostasis comrpising human gsk-3 |
| 01/03/2003 | WO2003000880A2 Homoaconitase as a target for fungicides |
| 01/03/2003 | WO2003000878A2 Use of fkbp chaperones as expression tool |
| 01/03/2003 | WO2003000877A2 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | WO2003000876A1 A proces for the preparation and purification of the enzyme pectin methyl esterase |
| 01/03/2003 | WO2003000875A2 Vitamin b6-phosphate phosphatase |
| 01/03/2003 | WO2003000874A2 Regulation of human serine/threonine protein kinase nek3 |
| 01/03/2003 | WO2003000873A2 Regulation of human serine/threonine protein kinase nek1 |
| 01/03/2003 | WO2003000867A1 Yeast transformation vector containing auxotrophic dominant gene, yeast transformant containing it and their preparation |
| 01/03/2003 | WO2003000858A2 Pharmacological targeting of bacterial dna ligase for treatment and prevention of bacterial infections |
| 01/03/2003 | WO2003000850A2 Dendritic cell transmembrane serine protease |
| 01/03/2003 | WO2003000844A2 Protein modification and maintenance molecules |
| 01/03/2003 | WO2003000842A2 Novel proteins and nucleic acids encoding same |
| 01/03/2003 | WO2003000840A2 Nitrilases |
| 01/03/2003 | WO2003000722A1 Multi-copper oxidase protein enzymes for iron(ii) acquisition in prokaryotic cells |
| 01/03/2003 | WO2003000721A2 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | WO2003000715A1 Chimeric histone acetyltransferase polypeptides |
| 01/03/2003 | WO2003000279A1 GEMININ AND orc3N INHIBIT REPLICATION OF HERPESVIRUSES, PAPILLOMAVIRUSES, AND POLYOMAVIRUSES |
| 01/03/2003 | WO2003000193A2 Covalent coupling of botulinum toxin with polyethylene glycol |
| 01/03/2003 | WO2003000041A1 Method of constructing transgenic plant with improved amino acid composition and yield |
| 01/03/2003 | WO2002083667A3 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/03/2003 | WO2002060939A3 Method for increasing the sulphur-compound content in plants |
| 01/03/2003 | WO2002055725A9 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production |
| 01/03/2003 | WO2002050163A3 Reduced byproduct high solids polyamine-epihalohydrin compositions |
| 01/03/2003 | WO2002048327A3 Compositions containing bioemulsifiers and a method for their preparation |
| 01/03/2003 | WO2002046377A3 Abscisic acid 8'- and 7'- hydroxylase genes and related sequences from plants |
| 01/03/2003 | WO2002044349A3 INCORPORATION AND PRIMING FUNCTION OF tRNALYS IN HIV AND RELATED VIRUSES |
| 01/03/2003 | WO2002040635A9 HUMAN RNase H1 MUTANTS |
| 01/03/2003 | WO2002012471A3 Angiotensin converting enzyme homolog and uses therefor |
| 01/03/2003 | WO2002008402A3 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same |
| 01/03/2003 | WO2002008187A9 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/03/2003 | WO2002004653A3 Sinapoylglucose : malate sinapoyltransferase forms malate conjugates from benozic acid glucosides |
| 01/03/2003 | WO2002004611A3 Aminoacyl trna synthetases |
| 01/03/2003 | WO2002002757A3 Adenylyl and guanylyl cyclases |
| 01/03/2003 | WO2002002627A3 Interferon-like protein zcyto21 |
| 01/03/2003 | WO2002000856A3 Protein glycosylation modification in pichia pastoris |
| 01/03/2003 | WO2001098470A3 Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same |
| 01/03/2003 | WO2001098468A3 Proteases |
| 01/03/2003 | WO2001083800A8 Heterologous production of polyketides |
| 01/03/2003 | WO2001064899A8 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method |
| 01/03/2003 | WO2001034902A3 Process and composition for preparing a lignocellulose-based product, and the product obtained by the process |
| 01/03/2003 | CA2790034A1 Antisense modulation of superoxide dismutase 1, soluble expression |
| 01/03/2003 | CA2770453A1 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | CA2677781A1 Nitrilases |
| 01/03/2003 | CA2451654A1 Chimeric histone acetyltransferase polypeptides |
| 01/03/2003 | CA2451026A1 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | CA2451002A1 Cytochrome p-450 gene cluster from rhodococcus ruber and uses thereof in ether fuel cleavage |
| 01/03/2003 | CA2450921A1 Protein modification and maintenance molecules |
| 01/03/2003 | CA2450792A1 Homoaconitase as a target for fungicides |
| 01/03/2003 | CA2449378A1 Vitamin b6-phosphate phosphatase |
| 01/02/2003 | US20030005482 Nucleotide sequences coding enzymatic polypeptide for use in the generation of stress and disease resistant plants |
| 01/02/2003 | US20030005477 Transgenic mice containing beta3GalT2 gene disruptions |
| 01/02/2003 | US20030005475 Transgenic mice containing acylphosphatase gene disruptions |
| 01/02/2003 | US20030005474 Transgenic rodent for use as tool in the diagnosis and treatment of nervous system disorders |
| 01/02/2003 | US20030004651 Crystalline TNF-alpha-converting enzyme and uses thereof |
| 01/02/2003 | US20030004328 Controlling phosphorylation |
| 01/02/2003 | US20030004325 Stability; nuclease resistance |
| 01/02/2003 | US20030004299 Culture using yeast cells |
| 01/02/2003 | US20030004164 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004162 Antidiabetic agents; dietetics |
| 01/02/2003 | US20030004161 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004139 Antidiabetic agents |
| 01/02/2003 | US20030004125 Controlling gene expression; antitumor agent |
| 01/02/2003 | US20030004103 Modulators of activity of G-protein-coupled receptor kinases |
| 01/02/2003 | US20030004102 Genetic engineering; immunosuppressants, anticancer agents |
| 01/02/2003 | US20030004093 Method for identifying compounds for inhibition of neoplastic lesions |
| 01/02/2003 | US20030003567 Packaging cells |
| 01/02/2003 | US20030003562 Mucleotide sequences coding polypeptide for use in the diagnosis of cancer |
| 01/02/2003 | US20030003561 Nucleotide sequences coding polypeptide for use in the baking and detergents |
| 01/02/2003 | US20030003560 Isolated human casein kinase proteins, nucleic acid molecules encoding human casein kinase proteins, and uses thereof |
| 01/02/2003 | US20030003559 Nucleotide sequences coding polypeptide for use in the treatment of diabetes, kidney, and liver disorders |
| 01/02/2003 | US20030003558 Nucleotide sequences coding enzymatic polypeptide for use in the generation of medicine, animal nutrients and foods |
| 01/02/2003 | US20030003557 Nucleotide sequences coding polypeptide for use in the generation of disease and herbicide resistant plants |
| 01/02/2003 | US20030003556 Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same |
| 01/02/2003 | US20030003551 Method for producing dihydroxyacetone-3-phosphate |
| 01/02/2003 | US20030003550 Microorganism for use in the generation of glutamine; for use in maintaining liver health |
| 01/02/2003 | US20030003548 Nucleotide sequences for use in the generation of animal nutrition, foods, pharmacology and human medicine |
| 01/02/2003 | US20030003539 Nucleotide sequences coding polypeptide for use in the treatment of blood, apoptosis, inflamation and brain disorders |
| 01/02/2003 | US20030003531 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/02/2003 | US20030003530 Nucleotide sequences coding protein for use in diagnosis and treatment of skin and cancer disorders |
| 01/02/2003 | US20030003529 Vitro modification of glycosylation patterns of recombinant glycopeptides |
| 01/02/2003 | US20030003528 Generation of carotenoid compound; obtain gnetically engineeered cell, incubate with carbon substrate, recover carotene compound |
| 01/02/2003 | US20030003488 Organelle enzymatic polypeptide for use in the treatment of tumors |
| 01/02/2003 | US20030003477 Nucleotide sequences coding polypeptides for use in the treatment of nervous system, kidney, muscle, allergic and cancer disorders |
| 01/02/2003 | US20030003471 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants |
| 01/02/2003 | US20030003469 Ribozyme treatment of diseases or conditions related to levels of NF-kappaB |
| 01/02/2003 | US20030003461 Truncation selex method |
| 01/02/2003 | US20030003453 DNA molecule encoding a variant paraoxonase and uses thereof |
| 01/02/2003 | US20030003452 Polymerase for use in the treatment of infections, respiratory, blood, alzheimer's, muscular and cancerous disorders |
| 01/02/2003 | US20030003097 Recombinant antibodies coexpressed with GnTIII |
| 01/02/2003 | US20030003096 Only specifically binds activated factor VII, and not factor VII, and does not bind to an activated factor VII which is complexed with antithrombin III |
| 01/02/2003 | US20030003093 Human beta-alanine-pyruvate aminotransferase |
| 01/02/2003 | US20030003086 A genetic engineered cell comprising an exogenously derived nucleic acid coding for a thimet oligopeptidase (TOP) polypeptide; modulate antigen presentation on cell surfaces, works synergistically with immunosuppressive drugs |